Quantitative Phosphoproteomics Analysis of ERBB3/ERBB4 Signaling

• DOI: 10.1371/journal.pone.0146100
• Publication Date: 2016-01-08T18:45:37Z
• Authors: Sebastian K. Wand...; Idoya Lahortiga; Kris Jacobs; Martin Klammer; Nicole Jordan; Sarah Elschenbroich; Marc Parade; Edgar Jacoby; Joannes T. M. Lin...; Dirk Brehmer; Jan Cools; Henrik Daub
• Keywords: 0301 basic medicine; Receptor, ErbB-4; Proteome; Receptor, ErbB-3; Science; Neuregulin-1; Molecular Sequence Data; RIBOSOMAL S6 KINASE; FEEDBACK PHOSPHORYLATION; OVARIAN-CANCER; Cell Line; Mice; 03 medical and health sciences; Protein Interaction Mapping; Animals; Humans; Gene Regulatory Networks; INTRACELLULAR DOMAIN; Amino Acid Sequence; Phosphorylation; IN-VIVO; TYROSINE PHOSPHORYLATION; B-Lymphocytes; Science & Technology; Q; BAD PHOSPHORYLATION; R; BREAST-CANCER CELLS; Phosphoproteins; Multidisciplinary Sciences; Gene Expression Regulation; Science & Technology - Other Topics; Medicine; PROTEIN-PHOSPHORYLATION; Genetic Engineering; ORBITRAP MASS-SPECTROMETER; Research Article; Protein Binding; Signal Transduction

The four members of the epidermal growth factor receptor (EGFR/ERBB) family form homo- and heterodimers which mediate ligand-specific regulation of many key cellular processes in normal and cancer tissues. While signaling through the EGFR has been extensively studied on the molecular level, signal transduction through ERBB3/ERBB4 heterodimers is less well understood. Here, we generated isogenic mouse Ba/F3 cells that express full-length and functional membrane-integrated ERBB3 and ERBB4 or ERBB4 alone, to serve as a defined cellular model for biological and phosphoproteomics analysis of ERBB3/ERBB4 signaling. ERBB3 co-expression significantly enhanced Ba/F3 cell proliferation upon neuregulin-1 (NRG1) treatment. For comprehensive signaling studies we performed quantitative mass spectrometry (MS) experiments to compare the basal ERBB3/ERBB4 cell phosphoproteome to NRG1 treatment of ERBB3/ERBB4 and ERBB4 cells. We employed a workflow comprising differential isotope labeling with mTRAQ reagents followed by chromatographic peptide separation and final phosphopeptide enrichment prior to MS analysis. Overall, we identified 9686 phosphorylation sites which could be confidently localized to specific residues. Statistical analysis of three replicate experiments revealed 492 phosphorylation sites which were significantly changed in NRG1-treated ERBB3/ERBB4 cells. Bioinformatics data analysis recapitulated regulation of mitogen-activated protein kinase and Akt pathways, but also indicated signaling links to cytoskeletal functions and nuclear biology. Comparative assessment of NRG1-stimulated ERBB4 Ba/F3 cells revealed that ERBB3 did not trigger defined signaling pathways but more broadly enhanced phosphoproteome regulation in cells expressing both receptors. In conclusion, our data provide the first global picture of ERBB3/ERBB4 signaling and provide numerous potential starting points for further mechanistic studies.